Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD

from JIMD Podcasts · host Journal of Inherited Metabolic Disease

Dr Claire Horgan discusses the first year of offering gene therapy to patients with metachromatic leukodystrophy (MLD) in the UK. When given in a timely fashion the impact is incredible but large numbers of children remain ineligible for treatment. A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead Claire Horgan, et al https://doi.org/10.1002/jmd2.12378

Episode metadata supplied by the publisher feed · Published Oct 19, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD

0:00 5:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JIMD Podcasts?

This episode is 5 minutes long.

When was this JIMD Podcasts episode published?

This episode was published on October 19, 2023.

Can I download this JIMD Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!